266 related articles for article (PubMed ID: 25480691)
21. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
[TBL] [Abstract][Full Text] [Related]
22. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
Elliott MA; Tefferi A
Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708
[TBL] [Abstract][Full Text] [Related]
23. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.
Thiele J; Kvasnicka HM; Muehlhausen K; Walter S; Zankovich R; Diehl V
Pathol Res Pract; 2001; 197(2):77-84. PubMed ID: 11261821
[TBL] [Abstract][Full Text] [Related]
24. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
25. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
Tefferi A; Elliott M; Pardanani A
Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036
[TBL] [Abstract][Full Text] [Related]
26. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
[TBL] [Abstract][Full Text] [Related]
27. Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly.
Fathi AT; Graubert TA; Kulkarni NM; Kuo FC; Hasserjian RP
N Engl J Med; 2016 Dec; 375(23):2273-2282. PubMed ID: 27959687
[No Abstract] [Full Text] [Related]
28. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
[TBL] [Abstract][Full Text] [Related]
29. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
Cui Y; Li B; Gale RP; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
J Hematol Oncol; 2014 Oct; 7():77. PubMed ID: 25316523
[TBL] [Abstract][Full Text] [Related]
30. Changes in allele frequencies of
Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA
Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656
[No Abstract] [Full Text] [Related]
31. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
Fleischman AG; Maxson JE; Luty SB; Agarwal A; Royer LR; Abel ML; MacManiman JD; Loriaux MM; Druker BJ; Tyner JW
Blood; 2013 Nov; 122(22):3628-31. PubMed ID: 24081659
[TBL] [Abstract][Full Text] [Related]
32. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT; Tyner JW; Gotlib J
Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
[TBL] [Abstract][Full Text] [Related]
33. Presence of the bcr/abl rearrangement in a patient with chronic neutrophilic leukaemia.
Christopoulos C; Kottoris K; Mikraki V; Anevlavis E
J Clin Pathol; 1996 Dec; 49(12):1013-5. PubMed ID: 9038742
[TBL] [Abstract][Full Text] [Related]
34. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
35. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
Drexler HG; Nagel S; Quentmeier H
Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
[TBL] [Abstract][Full Text] [Related]
36. Chronic neutrophilic leukemia with acute myeloblastic transformation.
Katsuki K; Shinohara K; Takeda K; Ariyoshi K; Yamada T; Kameda N; Takahashi T; Nawata R; Shibata S; Asano Y; Okamura S
Jpn J Clin Oncol; 2000 Aug; 30(8):362-5. PubMed ID: 11059343
[TBL] [Abstract][Full Text] [Related]
37. A case of chronic neutrophilic leukemia successfully treated with pegylated interferon alpha-2a.
Yassin MA; Kohla S; Al-Sabbagh A; Soliman AT; Yousif A; Moustafa A; Battah AA; Nashwan A; Al-Dewik N
Clin Med Insights Case Rep; 2015; 8():33-6. PubMed ID: 25983565
[TBL] [Abstract][Full Text] [Related]
38. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
Campr V
Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
[TBL] [Abstract][Full Text] [Related]
39. Expression of mu-BCR-ADL transcripts in chronic neutrophilic leukemia.
Cioc AM; Nuovo GJ
Am J Clin Pathol; 2002 Dec; 118(6):842-7. PubMed ID: 12472276
[TBL] [Abstract][Full Text] [Related]
40. Chronic neutrophilic leukemia evolving from polycythemia vera with multiple chromosome rearrangements: a case report.
Billio A; Venturi R; Morello E; Rosanelli C; Pescosta N; Coser P
Haematologica; 2001 Nov; 86(11):1225-6. PubMed ID: 11694412
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
